IP Library Granted Patent US 11,149,303
Granted Patent B2
US 11,149,303 · App. 16/537,160 · Granted Oct 19, 2021

Methods of depleting a target nucleic acid in a sample and kits for practicing the same

Inventors: Andrew Alan Farmer (Los Altos, CA); Ian B. Oglesby (Mountain View, CA); Magnolia Bostick (San Mateo, CA); Steve Oh (Sunnyvale, CA)
Assignee: Takara Bio USA, Inc.
C12Q1/6848C12Q1/6806
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,149,303
App. No.
16/537,160
Granted
Oct 19, 2021
Kind
B2
Abstract

Provided are methods of depleting a target nucleic acid in a sample. The methods include contacting a target nucleic acid with two or more polymers that specifically hybridize to the target nucleic acid, and cleaving the hybridized regions of the target nucleic acid to deplete the target nucleic acid in the sample. Kits for practicing the subject methods are also provided.

Claims (26)

1. A kit comprising:

a polymer cocktail comprising two or more polymers configured to collectively hybridize to less than 80% of a same target nucleic acid, wherein each of the two or more polymers specifically hybridize to distinct regions of the same target nucleic acid to generate hybridized regions of the target nucleic acid that are separated by a gap;

a nuclease capable of specifically cleaving the distinct regions of the target nucleic acid when the two or more polymers are hybridized to the target nucleic acid;

wherein the polymer cocktail is configured to remove the target nucleic acid from a sample comprising the polymer cocktail, the target nucleic acid and the nuclease.

2. The kit according to claim 1 , wherein the target nucleic acid is a ribonucleic acid (RNA).

3. The kit according to claim 1 , wherein the target nucleic acid is a deoxyribonucleic acid (DNA).

4. The kit according to claim 1 , wherein the two or more polymers are independently selected from the group consisting of: a DNA oligonucleotide, an RNA oligonucleotide, a locked nucleic acid (LNA), a peptide nucleic acid (PNA), and a xeno nucleic acid (XNA).

5. The kit according to claim 1 , wherein the kit further comprises a component for removing the two or more polymers from a reaction mixture.

6. The kit according to claim 5 , wherein the component for removing the two or more polymers from a reaction mixture is an enzyme.

7. The kit according to claim 6 , wherein the two or more polymers comprise deoxyuridine triphosphate (dUTP).

8. The kit according to claim 7 , wherein the enzyme is uracil-N-glycosylase (UDG).

9. The kit according to claim 5 , wherein the component for removing the two or more polymers is a solid support to which the two or more polymers bind.

10. The kit according to claim 1 , wherein the nuclease is a ribonuclease.

11. The kit according to claim 10 , wherein the ribonuclease is selected from the group consisting of RNase H and RNase V.

12. The kit according to claim 1 , wherein the nuclease is a deoxyribonuclease.

13. The kit according to claim 1 , comprising a buffer compatible with the nuclease.

14. The kit according to claim 1 , comprising reagents for isolating nucleic acids from a nucleic acid source.

15. The kit according to claim 1 , wherein the polymer cocktail comprises 3 or more polymers.

16. The kit according to claim 1 , wherein the polymer cocktail comprises 4 or more polymers.

17. The kit according to claim 1 , wherein the polymer cocktail comprises 2 to 30 polymers.

18. The kit according to claim 1 , wherein the two or more polymers are 10 to 200 nucleotides in length.

19. The kit according to claim 1 , wherein the two or more polymers are 10 to 50 nucleotides in length.

20. The kit according to claim 1 , wherein the polymer cocktail comprises polymers that hybridize to two or more different target nucleic acids.

21. The kit according to claim 1 , wherein the two or more polymers are unlabeled.

22. The kit according to claim 2 , wherein the ribonucleic acid is selected from the group consisting of: a ribosomal RNA (rRNA), a precursor messenger RNA (pre-mRNA), a micro RNA (miRNA), a transfer RNA (tRNA), a mitochondrial RNA (mtRNA), and any combination thereof.

23. The kit according to claim 22 , wherein the ribonucleic acid is a ribosomal ribonucleic acid (rRNA).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2019
From: FARMER, ANDREW ALAN; OGLESBY, IAN B.; BOSTICK, MAGNOLIA; OH, STEVE
To: CLONETECH LABORATORIES, INC.
Reel/Frame 051304/0578 →
CHANGE OF NAME Recorded Dec 17, 2019
From: CLONETECH LABORATORIES, INC.
To: TAKARA BIO USA, INC.
Reel/Frame 051304/0591 →
Continuity (4)
Division 15217923 · Jul 22, 2016
Continuation 14023354 · Sep 10, 2013
Provisional Application 61700727 · Sep 13, 2012
Related Publication 20190360032A1 · Nov 28, 2019